Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
|Videos|July 9, 2017
Mark Gibbons on Caregivers of Patients with Ovarian Cancer
Author(s)Mark Gibbons
Mark Gibbons of Caregiver Action Network discusses the emotions caregivers to patients with ovarian cancer may have.
Advertisement
Mark Gibbons of Caregiver Action Network discusses the emotions caregivers to patients with ovarian cancer may have. There are many questions that can come up and it can help a caregiver to know that they are not alone in feeling and thinking about certain things.
Advertisement
Related to this article
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Dr. Sara Hurvitz explains why giving Enhertu before surgery didn't change care for HER2-low, HR-positive early breast cancer, and what patients should know.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient cancer.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Glioblastoma Patients Can Request Genomic Testing on Their Tumor Tissue
3
Weight Loss With Pancreatic Cancer: Why It Happens and What Helps
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5